Skip to main content

Table 1 Frequency distribution of patients hospitalized for Covid-19 Pneumonia according to demographic characteristics and comorbidities

From: Clinical outcome of patients with COVID-19 Pneumonia treated with corticosteroids and colchicine in Colombia

Variable

Treatment

Total patients (n = 301)

Pearson’s Chi-Squared p-value

Corticosteroids (n = 95)

Corticosteroids AndColchicine (n = 145)

Without Corticosteroids (n = 61)

Age

55.9 (± 18)

59.1 (± 16.5)

53.7 (± 17.5)

56.8 (± 17.3)

Sex

 

 Male

61 (64.2%)

75 (51.7%)

42 (68.9%)

178 (59.1%)

0.04

 Female

34 (35.8%)

70 (48.3%)

19 (31.1%)

123 (40.9%)

Comorbidities

71 (74.7%)

109 (75.2%)

45 (73.8%)

225 (74.8%)

0.98

Cancer

5 (5.3%)

9 (6.2%)

2 (3.3%)

16 (5.3%)

0.69

Hypothyroidism

4 (4.2%)

18 (12.4%)

7 (11.5%)

29 (9.6%)

0.09

Heart disease

1 (1%)

5 (3.5%)

1 (1.9%)

7 (2.3%)

0.45

Renal failure

2 (2.1%)

12 (8.3%)

4 (6.6%)

18 (5.9%)

0.14

Dementia

2 (2.1%)

6 (4.1%)

4 (6.6%)

12 (3.9%)

0.38

Obesity

22 (23.2%)

15 (10.3%)

5 (8.2%)

42 (13.9%)

0.007

COPD

12 (12.6%)

15 (10.3%)

3 (4.9%)

30 (9.9%)

0.29

Diabetes mellitus

21 (22.1%)

38 (26.2%)

14 (22.9%)

73 (24.3%)

0.74

Hypertension

44 (46.3%)

67 (46.2%)

26 (42.6%)

137 (45.5%)

0.88

Dyslipidemia

4 (4.2%)

19 (13.1%)

4 (6.6%)

27 (8.9%)

0.05

Autoimmune disease

3 (3.2%)

1 (0.7%)

3 (4.9%)

7 (2.3%)

0.15

Psychiatric disease

1 (1.1%)

5 (3.4%)

1 (1.6%)

7 (2.3%)

0.45

Neurological disease

6 (6.3%)

1 (0.7%)

4 (6.6%)

11 (3.7%)

0.03

Coronary disease

5 (5.3%)

11 (7.6%)

2 (3.3%)

18 (5.9%)

0.46

Tobacco addiction

11 (11.6%)

14 (9.7%)

9 (14.8%)

34 (11.3%)

0.57